At-home care of kids with leukemia prone to errors

	Tweet

When children with acute lymphoblastic leukemia (ALL) are cared for at home, medication errors occur in about one in five cases, according to a new study. Although the errors encountered in the study were mostly trivial, some could reduce treatment efficacy or increase the side effects of treatment.

Most information about medication errors comes from hospital settings, Dr. James A. Taylor and his team note in their report in the journal Cancer. They propose that mistakes may be even more common when medications are administered by parents to their children.

The research team investigated this possibility at the Children’s Hospital and Regional Medical Center in Seattle over a 2-month period in 2005. The subjects were 69 children undergoing treatment for a first bout with leukemia, and their caregivers.

The investigators asked the caregivers to describe and demonstrate how medications were being given, and to tell when, how often and for how long each drug was used.

Overall, 172 chemotherapy meds were administered. At least one medication error occurred with 17 of them (10 percent). Twelve were administration errors (by the caregiver) and five were prescribing errors (by the physician), involving 13 children (19 percent).

The authors note that most of the errors had little clinical significance. However, three children had a higher risk of relapse and one ran a higher risk of infection because of the mistakes.

Nevertheless, Taylor and his associates report, the results show that parents are as capable of administering oral chemo drugs as well as medical professionals, who have been shown in previous research to make even more errors.

SOURCE: Cancer, online August 14, 2006.

RELATED STORIES:
China scientists show how arsenic treats blood cancer   X-rays linked to increased childhood leukemia risk   Researchers Unlock Mystery of Very Aggressive Leukemia   2 genes cooperate to cause aggressive leukemia   Childhood Leukemia Survivors Struggle With Long-Term Comorbidities   Stress Hormone May Hasten the Progression of Certain Blood Cancers   Drug That Modifies Gene Activity Could Help Some Older Leukemia Patients   Researchers Seek Alternative for Leukemia Patients Resistant to Standard Therapies   Weill Cornell drug stops aggressive form of childhood leukemia   A Collaboration to Find New Tools to Fight Leukemia   New Therapeutic Options for Newly Diagnosed Multiple Myeloma Patients   Individualizing Treatment for Multiple Myeloma Patients   2 genetic variations predict second cancers after radiation for children with Hodgkin lymphoma   Celgene drug boosts multiple myeloma survival   Green tea may curb risk of some cancers   Finding indicate why some kinds of Leukemia are more aggressive than others   New Recommendations for Use of Bisphosphonates in Treatment of Multiple Myeloma   No link between leukemia risk and nuclear plants   Mouse Mimics Chronic Leukemia, Will Aid Drug Development   Hodgkin’s survivors at increased risk for leukemia   Formaldehyde raises risk of deadly cancers: study   White Blood Cell Count, Inflammation Linked to Cancer Deaths

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]